Pharmaceutical Groups Will Not Contest Kenyan AIDS Drug LawJune 14, 2001 On Wednesday, pharmaceutical representatives said they will not contest Kenya's Industrial Property Bill. The measure, which was given unanimous approval by the Kenyan Parliament on Tuesday, will allow the government to import cheaper brand name and generic drugs. "We are not against cheap generic drugs, as long as they have to go through the same registration process and the same quality control," said Doshi Niraj of Merck. Agence France Presse 06.13.01 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|